Navigation Links
2012 Gastroinstestinal Cancers Symposium reveals new advances aimed at improving treatment, prognosis and detection of GI cancers
Date:1/17/2012

ALEXANDRIA, Va. New research into the treatment, prognosis and early detection of gastrointestinal cancers was released today in advance of the ninth annual Gastrointestinal Cancers Symposium being held January 19-21, 2012, at The Moscone West Building in San Francisco, Calif.

Four important studies were highlighted today in a live presscast:

1)Biomarkers Promising for Detecting Barrett's Esophagus Patients at High Risk for Esophageal Cancer: Newly found biomarkers could eventually improve early detection of esophageal cancer in patients with Barrett's esophagus (BE), a condition that significantly increases esophageal cancer risk. Using a special microscope, researchers identified three optical biomarkers in cells of the esophagus lining, which enabled them to stratify patients' risks of progressing to cancer.

2) New Test Shows Promise for Detecting Early Stage Pancreatic Cancer: A new blood-based biomarker test correctly identified nearly two-thirds of patients with early stage pancreatic cancer, which has historically been extremely difficult to detect. When combined with another tumor marker commonly used to monitor disease progression, the new test found 85 percent of patients with pancreatic cancer.

3) Study Finds Prognostic Factors for Rare Neuroendocrine Tumors, Suggests Everolimus May Be More Beneficial Than Previously Shown: Researchers re-analyzing the results of a large phase III study of patients with advanced neuroendocrine tumors (NET) found certain factors predict which individuals are at greatest risk for neuroendocrine tumor progression and more likely to need active therapy. The re-analysis also showed that combining the drug everolimus (Afinitor) with another drug, octreotide, halted tumor growth for a longer period that previously shown, compared to octreotide alone.

4) Multi-Targeted Drug Improves Survival in Certain Patients with Metastatic Colorectal Cancer: An international phase III trial s
'/>"/>

Contact: Susie Tappouni
susie.tappouni@asco.org
571-483-1355
American Society of Clinical Oncology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Gene links rare and unrelated cancers
2. Wistar receives $4.7 million to develop drug against Epstein-Barr virus-related cancers
3. Key genetic error found in family of blood cancers
4. A gene that protects against colorectal cancers
5. Heart drug may be effective for managing certain cancers: Queens University study
6. Two New Drug Combos May Fight Advanced Breast Cancers
7. Family Tree May Affect Diagnosis Age in Some Breast Cancers
8. British Screening Program Finding More Early Stage Colon Cancers
9. HIV Patients at Heightened Risk for Certain Cancers
10. BRAF addiction of thyroid cancers makes them therapeutically vulnerable
11. New drug combo targets multiple cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17 (HealthDay News) -- There are apps that turn ... a GPS system, and now there,s an app that may ... attack. The app, which was designed by engineers and ... severe heart attacks, called STEMIs, before patients get to the ... but it has undergone field testing. In a STEMI ...
(Date:5/17/2013)... a higher burden of disease and lower life expectancy ... of men are notably absent from the strategies of ... this week,s Lancet . , The article reinterprets ... which shows that all of the top ten causes ... risk factors driving rates of ill-health around the world, ...
(Date:5/17/2013)... Florida Hospital Tampa is ... and implement programs providing education, support and development to ... special emphasis on health-related initiatives and those events which ... partnership started in January of 2012 with the formal ... until March 19, 2015. The cooperative educational program entitled, ...
(Date:5/17/2013)... 17 (HealthDay News) -- Teen bullies are more likely ... finds. UT Dallas researchers analyzed several decades of ... All of them had similar working-class backgrounds and most ... were in their mid-50s. Nearly half of the ... years engaged in some form of criminal activity -- ...
(Date:5/17/2013)... transplants to treat a common type of liver cancer ... according to new research. The Italian study, published ... found that the AIDS-causing virus doesn,t affect survival rates ... this particular type of liver cancer, called hepatocellular carcinoma ... more aggressive in people with HIV and it is ...
Breaking Medicine News(10 mins):Health News:Heart Attack? Doctors Soon May Have an App for That 2Health News:Heart Attack? Doctors Soon May Have an App for That 3Health News:Global health policy fails to address burden of disease on men 2Health News:Florida Hospital Tampa Partners with Hillsborough County Public Schools Offering Health Educational Programs and Support to Students 2Health News:Florida Hospital Tampa Partners with Hillsborough County Public Schools Offering Health Educational Programs and Support to Students 3Health News:HIV No Barrier to Getting Liver Transplant, Study Finds 2
... twice before buying their next pair of high-heels or pumps, ... Hebrew SeniorLife in a new study of older adults and ... women wear, specifically high-heels, pumps and sandals, may cause future ... who reported hind-foot pain regularly wore these types of shoes ...
... individuals from the field of pharmaceutical research are expected to ... - 12, 2009 at the Los Angeles Convention Center in ... have the opportunity to present new research, methods and technologies ... only is the meeting the premiere international event for the ...
... ... healthcare professionals, today announced that it has acquired the assets of Medical Concepts Staffing ... , ... (PRWEB) September 28, 2009 -- Temps Inc., ( www.tempsinc.net ) a national provider of ...
... cons of cancer screen not understood, research shows, , MONDAY, ... told the pros and cons of PSA tests, two new ... they can,t predict which cancers are aggressive and which are ... leads to overtreatment, which can have immediate consequences, such as ...
... cells to ignore premature signals to stop producing important proteins. ... Journal of Experimental Medicine , the findings could lead to ... dystrophy, that are sparked by missing proteins. "When DNA ... than the end of a protein-producing signal, they act like ...
... of Common Human Disease has been chosen as one ... of Health (NIH) grant for Centers of Excellence to ... million over five years. "We,re grateful for ... how epigenetic control affects disease," says the center,s director, ...
Cached Medicine News:Health News:Institute for Aging Research study links high-heels to heel and ankle pain 2Health News:Temps Inc. Acquires Medical Concepts Staffing Business From Analysts International Corporation 2Health News:Men Not Being Told Enough About PSA Tests 2Health News:Men Not Being Told Enough About PSA Tests 3Health News:Men Not Being Told Enough About PSA Tests 4Health News:UCLA study identifies 2 chemicals that could lead to new drugs for genetic disorders 2
(Date:5/16/2013)... NEW YORK , May 16, 2013 Developers ... and sends patient reminders have emerged as grand prize winners ... diabetes innovation challenge funded by Boehringer Ingelheim and organized by ... Josh Stein , John Langhauser ... AdhereTech from the United States ...
(Date:5/16/2013)... YORK , May 16, 2013 /PRNewswire/ ... company that develops innovative targeted payload immunotherapeutics ... the official program of TAT: Target Alpha ... presentation devoted to Actinium Pharmaceuticals, clinical programs.  ... Myeloid Leukemia with Bismuth-213 and Actinium-225" has ...
(Date:5/16/2013)... 16, 2013  Lakewood-Amedex Inc., a leading developer ... recent series of in vitro studies ... of antimicrobials, named bisphosphocins, function through a completely ... resulting in rapid direct bacterial killing.  These studies ... be superior to ciprofloxacin.  The studies revealed the ...
Breaking Medicine Technology:Wireless Pill Bottle Wins Healthcare Innovation World Cup 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 4Wireless Pill Bottle Wins Healthcare Innovation World Cup 5Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 2Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 3Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 2Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 3Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 4
... Mylan Inc. (Nasdaq: MYL ) today announced ... from the U.S. Food and Drug Administration (FDA) for its ... 8.5 mg, 17 mg, 25.5 mg and 34 mg. Mylan ... ANDA containing a Paragraph IV certification for Nisoldipine ER Tablets ...
... Inc. (Amex: AEN ), a developer of innovative ... it has executed an agreement for the sale of approximately ... share to two new institutional investors in a registered direct ... also receive warrants to purchase approximately 1.42 million shares of ...
Cached Medicine Technology:Adeona to Raise $4 Million in Registered Direct Offering 2Adeona to Raise $4 Million in Registered Direct Offering 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: